London, UK; Brentwood, TN, US; 17 January 2007 - Protherics PLC ("Protherics" or
the "Company"), the international biopharmaceutical company focused on critical
care and cancer, today announces that, on 16 January 2007, notification was
received from Artemis Investment Management Limited that, following the increase
in the share capital of Protherics which took place on 4 January 2007, Artemis
Income as beneficial owners of the shares within Artemis Investment Management
Ltd, no longer have a notifiable interest in the shares of Protherics.
